In models of diabetic kidney disease, excessive SMPDL3B expression impairs ceramide-1-phosphate synthesis and insulin receptor signaling, accelerating podocyte injury and glomerular decline [6]. This evidence concerns the gene INSR and diabetic kidney disease.